Llorens Pharmaceutical Corp.

FDA Regulatory Profile

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0081-2018Class IIUrin D/S Tablets Methenamine 81.6 mg, Sodium Biphosphate 40.8 mg, Phenyl Salicylate 36.2 mg, MethyleSeptember 5, 2017